Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Huan Jing Ke Xue ; 43(11): 4888-4904, 2022 Nov 08.
Artigo em Chinês | MEDLINE | ID: mdl-36437061

RESUMO

Since the late 1970s, marine ecotoxicology began to sprout and develop in China. Based on the principles of dose-response relationships, some marine organisms are used in toxicity tests to evaluate the impact of marine pollutants on marine organisms and marine ecosystems. At the early stage, marine ecotoxicological research mainly focused on the bioaccumulation, biomagnification, and biodegradation of traditional pollutants such as heavy metals, radioactive elements, organotin, petroleum hydrocarbons, and pesticides, as well as their toxic effects on survival, growth, and other physiological indicators. With the development of Chinese industry, marine pollution has become increasingly serious. In addition to the traditional marine pollutants, toxicological research has been conducted on emerging pollutants with potential risks to marine ecosystems, such as POPs, emerging organic pollutants, nanomaterials, and microplastics. Moreover, the species of marine organisms used in toxicity testing have become more diverse. The selection of testing organisms is essential for evaluating toxicity correctly. The toxicity tests should be conducted on a variety of organisms from different trophic levels to ensure the comprehensive understanding of the impact of pollutants on marine ecosystems. The major types of marine organisms used in the toxicity testing include marine alga, protozoa, rotifera, annelida, mollusc, echinoderma, arthropoda, cephalopoda, and marine fish, which have been used in the toxicological studies of various marine pollutants. The outcome results can serve as the scientific basis for the ecological risk assessment of marine pollutants and the establishment of seawater quality criteria. It should be noted that the sensitivity of different testing organisms to different types of pollutants is quite diverse. Therefore, in addition to conducting a battery of tests on a variety of species which play important roles in marine ecosystems, elucidating the toxic mechanisms in different species is also important for marine ecotoxicological studies. The application of the above-mentioned organisms in marine ecotoxicology research in recent years is briefly reviewed here. Particularly, the six commonly used marine model species (Skeletonema costatum, Euplotes vannus, oysters, sea urchins, Tigriopus japonicus, and Oryzias melastigma) used in toxicity testing are introduced in detail.


Assuntos
Poluentes Ambientais , Poluentes Químicos da Água , Animais , Ecotoxicologia , Ecossistema , Plásticos , Poluentes Químicos da Água/toxicidade , Poluentes Químicos da Água/análise , Testes de Toxicidade , Organismos Aquáticos
3.
Cell Tissue Res ; 314(2): 237-49, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12955496

RESUMO

The KAI1 gene is identified as a tumor metastasis suppressor gene in many types of cancer. We examined KAI1 gene and its protein KAI1/CD82 expression by in situ hybridization and immunohistochemical analysis, and found that KAI1 mRNA and protein expression were inversely correlated with lymph node and distant metastasis in digestive tract carcinomas, but not with age and gender of the patient, or with tumor differentiation. Moreover, KAI1/CD82 protein expression positively reflected the survival outcome of patients. Western blot analysis showed that VP-16 increased KAI1/CD82 protein expression obviously in various cancer cell lines, especially in those that were highly metastatic. This increased KAI1/CD82 expression was associated with its translocation from the cytomembrane to the nucleus, in which it interacted with nuclear p53 protein, forming a strong complex, observed by confocal microscopy and co-immunoprecipitation, respectively. In nude mice, after feeding with VP-16, the number of tumors metastasized from spleen to liver was obviously reduced, and KAI1/CD82 protein expression became stronger in those metastatic tumors. Accordingly, this demonstrated that KAI1 might be used as an indicator for predicting the clinical outcome, and VP-16 may be clinically considered as a promising candidate for anti-metastasis with regard to its potential to upregulate KAI1 expression.


Assuntos
Antígenos CD , Carcinoma/genética , Neoplasias Gastrointestinais/genética , Genes Supressores de Tumor , Proteínas Proto-Oncogênicas , Animais , Western Blotting , Carcinoma/patologia , Linhagem Celular Tumoral , Etoposídeo/farmacologia , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Neoplasias Gastrointestinais/patologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Proteína Kangai-1 , Fígado/patologia , Masculino , Glicoproteínas de Membrana , Camundongos , Camundongos Nus , Microscopia Confocal , Inibidores da Síntese de Ácido Nucleico/farmacologia , Testes de Precipitina , Proteínas/metabolismo , RNA Mensageiro/metabolismo , Baço/patologia , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA